Cerebral Small Vessel Disease

Cell Transplant. 2018 Dec;27(12):1711-1722. doi: 10.1177/0963689718795148. Epub 2018 Sep 25.

Abstract

Cerebral small vessel disease (CSVD) is composed of several diseases affecting the small arteries, arterioles, venules, and capillaries of the brain, and refers to several pathological processes and etiologies. Neuroimaging features of CSVD include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. The main clinical manifestations of CSVD include stroke, cognitive decline, dementia, psychiatric disorders, abnormal gait, and urinary incontinence. Currently, there are no specific preventive or therapeutic measures to improve this condition. In this review, we will discuss the pathophysiology, clinical aspects, neuroimaging, progress of research to treat and prevent CSVD and current treatment of this disease.

Keywords: Cerebral small vessel disease; MRI; arteriolosclerosis; cerebral amyloid angiopathy; dementia; neuroimaging; stroke syndrome.

Publication types

  • Review

MeSH terms

  • Arteriolosclerosis / pathology
  • Arteriolosclerosis / therapy
  • Cerebral Amyloid Angiopathy / pathology
  • Cerebral Amyloid Angiopathy / therapy
  • Cerebral Small Vessel Diseases / classification
  • Cerebral Small Vessel Diseases / drug therapy
  • Cerebral Small Vessel Diseases / pathology*
  • Humans
  • Magnetic Resonance Imaging
  • Platelet Aggregation Inhibitors / therapeutic use
  • Stroke / prevention & control
  • Tissue Plasminogen Activator / therapeutic use
  • White Matter / diagnostic imaging

Substances

  • Platelet Aggregation Inhibitors
  • Tissue Plasminogen Activator